These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8990252)

  • 21. Falsely elevated troponin I attributed to inadequate centrifugation using the Access immunoassay analyzer.
    Er TK; Tsai LY; Jong YJ; Chen BH
    Clin Chem Lab Med; 2006; 44(7):908-9. PubMed ID: 16776644
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of a modified lateral flow immunoassay for detection of high-sensitivity cardiac troponin I and myoglobin.
    Zhu J; Zou N; Mao H; Wang P; Zhu D; Ji H; Cong H; Sun C; Wang H; Zhang F; Qian J; Jin Q; Zhao J
    Biosens Bioelectron; 2013 Apr; 42():522-5. PubMed ID: 23247055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of decision limits for ACS:systems cardiac troponin I.
    Pagani F; Bonetti G; Stefini F; Cuccia C; Panteghini M
    Clin Chem Lab Med; 2000 Nov; 38(11):1155-7. PubMed ID: 11156348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False positive elevation of cardiac troponin I in seropositive rheumatoid arthritis.
    Bas S; Genevay S; Mensi N
    J Rheumatol; 2002 Dec; 29(12):2665. PubMed ID: 12465175
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of a rapid, quantitative cardiac troponin I immunoassay.
    Kuhr LP; Baum H; Schweigert R; Hafner G; Prellwitz W; Neumeier D
    Eur J Clin Chem Clin Biochem; 1997 May; 35(5):399-404. PubMed ID: 9189748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the 99th Percentile the Optimal Reference Limit to Diagnose Myocardial Infarction With High-Sensitivity Cardiac Troponin Assays in Patients With Chronic Kidney Disease?
    Chaitman BR
    Circulation; 2015 Jun; 131(23):2029-31. PubMed ID: 25948540
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of cardiac troponins for diagnosis 'acute myocardial infarct'].
    Gansevoort RT; Huisman RM; de Jongste MJ; Kema IP
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1273-4. PubMed ID: 11455696
    [No Abstract]   [Full Text] [Related]  

  • 28. [Access immunoassay system--troponin I and myocardial damage].
    Yamanaka S; Sugiura T
    Rinsho Byori; 2003 Jun; Suppl 126():84-9. PubMed ID: 12905946
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of high-sensitivity assays for cardiac troponin.
    Morrow DA; Antman EM
    Clin Chem; 2009 Jan; 55(1):5-8. PubMed ID: 19028812
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical prevalence and ramifications of false-positive cardiac troponin I elevations from the Abbott AxSYM Analyzer.
    McClennen S; Halamka JD; Horowitz GL; Kannam JP; Ho KK
    Am J Cardiol; 2003 May; 91(9):1125-7. PubMed ID: 12714162
    [No Abstract]   [Full Text] [Related]  

  • 31. [Kinetics of cardiac troponin I (TnIc) after angioplasty and interest in TnIc in unstable angina].
    Sadeg N; Jourdain P; Dumontet M; Funck F
    Ann Biol Clin (Paris); 2001; 59(3):323-8. PubMed ID: 11397683
    [No Abstract]   [Full Text] [Related]  

  • 32. Multicenter evaluation of the TOSOH AIA-pack second-generation cardiac troponin I assay.
    Pagani F; Stefini F; Micca G; Toppino M; Manoni F; Romano L; Hoffer P; Iervasi A; Caputo M; Dorizzi R; Zucchelli G; Panteghini M
    Clin Chem; 2004 Sep; 50(9):1707-9. PubMed ID: 15331518
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily monitoring of a control material with a concentration near the limit of detection improves the measurement accuracy of highly sensitive troponin assays.
    Aloisio E; Pasqualetti S; Dolci A; Panteghini M
    Clin Chem Lab Med; 2020 Jan; 58(2):e29-e31. PubMed ID: 31465291
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of rheumatoid factor on cardiac troponin I measurement using two commercial measurement systems.
    Onuska KD; Hill SA
    Clin Chem; 2000 Feb; 46(2):307-8. PubMed ID: 10657400
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction.
    Eggers KM; Jaffe AS; Venge P; Lindahl B
    Clin Chim Acta; 2011 Jan; 412(1-2):91-7. PubMed ID: 20869357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic alveolar rhabdomyosarcoma with increased serum creatine kinase MB and cardiac troponin T and normal cardiac troponin I.
    Isotalo PA; Greenway DC; Donnelly JG
    Clin Chem; 2000 Apr; 46(4):582. PubMed ID: 10790783
    [No Abstract]   [Full Text] [Related]  

  • 38. Specificity of cardiac markers troponin I and T in excluding postoperative myocardial infarction.
    Ben Ayed S; Godet G; Foglietti MJ; Bernard M
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():559-60. PubMed ID: 9293315
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical utility of cardiac troponin I and cardiac troponin T measurements.
    Adamcová M; Kokstein Z; Vávrová J
    Acta Medica (Hradec Kralove); 1997; 40(4):83-7. PubMed ID: 9481880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum. Elimination of this interference by using a polyclonal antisera against rheumatoid factors.
    Dasgupta A; Banerjee SK; Datta P
    Am J Clin Pathol; 1999 Dec; 112(6):753-6. PubMed ID: 10587696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.